Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun;8(3):181-91.
doi: 10.1177/1756287216632429. Epub 2016 Feb 24.

Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction

Yana Barbalat  1 , Marissa C Velez  1 , Christopher I Sayegh  1 , Doreen E Chung  2
Affiliations
Review

Evidence of the efficacy and safety of the thulium laser in the treatment of men with benign prostatic obstruction

Yana Barbalat et al. Ther Adv Urol. 2016 Jun.

Abstract

In 2005, the high power thulium laser was introduced for the surgical treatment of benign prostatic obstruction. It has several properties that confer theoretical advantages over other lasers used for the same indication, such as technical versatility and a relatively small zone of thermal damage. Studies using the 70-150 W thulium laser systems demonstrate good efficacy of these procedures with low morbidity and few complications even in higher risk patients. Different techniques have been employed to treat the prostate with this technology, including enucleation, vapoenucleation, vaporization and resection. Comparative studies have been published comparing thulium laser prostatectomy to monopolar transurethral resection of prostate (TURP), bipolar TURP and holmium laser enucleation of prostate (HoLEP). In this review we discuss the current literature on the safety and efficacy of various thulium techniques for the treatment of benign prostatic hyperplasia and examine comparative studies.

Keywords: laser therapy; prostatic hyperplasia; thulium.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare no conflicts of interest in preparing this article.

References

    1. Bach T., Hermann T., Ganzer R., Burchardt M., Gross A. (2007) Revolix vaporesection of the prostate: initial results of 54 patients with 1-year follow-up. World J Urol 25: 257–262. - PubMed
    1. Bach T., Hermann T., Hacker A., Michel M., Gross A. (2009a) Thulium:yttrium-aluminum-garnet laser prostatectomy in men with refractory urinary retention. BJU Int 104: 361–364. - PubMed
    1. Bach T., Wendt-Nordahl G., Michel M., Hermann T., Gross A. (2009b) Feasibility and efficacy of thulium:yag laser enucleation (vapoenucleation) of the prostate. World J Urol 27: 541–545. - PubMed
    1. Brunckhorst O., Ahmed K., Nehikhare O., Marra G., Challacombe B., Popert R. (2015) Evaluation of the learning curve for holmium laser enucleation of the prostate using multiple outcome measures. Urology 86: 824–829. - PubMed
    1. Carmignani L., Bozzini G., Macchi A., Maruccia S., Picozzi S., Casellato S. (2015) Sexual outcome of patients undergoing thulium laser enucleation of the prostate for benign prostatic hyperplasia. Asian J Androl 17: 802–806. - PMC - PubMed

LinkOut - more resources